Clinical Trial

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The investigators conduct a single-center, prospective, observational study to explore the value of EUS-guided portal vein circulating tumor cells (PV-CTCs) and their subtypes combined with multi-omics tests in the early warning of recurrence and metastasis of resectable pancreatic cancer(RPC) and borderline resectable pancreatic cancer (BRPC).
Trial Details
NCT Number NCT07448376
Lead Sponsor Huazhong University of Science and Technology
Conditions CTCs, Pancreatic Cancer, Liver Metastases, Relapse, Borderline Resectable Pancreatic Cancer, Resectable Pancreatic Cancers, EUS
Enrollment 20 participants
Start Date 2026-03-01
Primary Completion 2027-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-04